search
Back to results

Cyclization of Motor Cortex Stimulation

Primary Purpose

Neuropathic Pain

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
motor cortex stimulation (Change of Stimulation Timing)
Sponsored by
University of British Columbia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neuropathic Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patient more than 18 years of age
  • Chronic neuropathic pain effectively treated with motor cortex stimulation
  • Stable medication during the trial
  • Willing and able to comply with the study protocol and to return per the follow-up visit schedule and able to provide informed consent.

Exclusion Criteria:

  • Evidence of an active disruptive psychiatric disorder or other known condition significant enough to impact the perception of pain, compliance to intervention and/or ability to evaluate treatment outcome as determined by the investigator
  • Technical malfunction of the MCS device
  • History of seizures
  • Unable to provide informed consent

Sites / Locations

  • The Vancouver General Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Experimental

Experimental

Experimental

Arm Label

Original Setting- MCS 30 min off/0 min off

MCS 25 min on/5 min off

MCS 20 min on/10 min off

MCS 15 min on/15 min off

Arm Description

Patients at baseline with their original MCS settings: on 30 minutes, off 0 minutes in any single half-hour.

Patient MCS settings programmed to: on 25 minutes, off 5 minutes in any single half-hour.

Patient MCS settings programmed to: on 20 minutes, off 10 minutes in any single half-hour.

Patient MCS settings programmed to: on 15 minutes, off 15 minutes in any single hour.

Outcomes

Primary Outcome Measures

Change in Pain measured on the Visual Analogue Scale (VAS) with different stimulation settings

Secondary Outcome Measures

Quality of Life assessment with the SF-36 questionnaire

Full Information

First Posted
June 4, 2015
Last Updated
October 29, 2020
Sponsor
University of British Columbia
search

1. Study Identification

Unique Protocol Identification Number
NCT02465918
Brief Title
Cyclization of Motor Cortex Stimulation
Official Title
The Relationship Between Cyclizing Stimulation and Effective Stimulation During Motor Cortex Stimulation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
July 2015 (undefined)
Primary Completion Date
July 2016 (Actual)
Study Completion Date
July 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of British Columbia

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Motor cortex stimulation (MCS) is a form of brain stimulation for patients with neuropathic pain not responsive to medication. An electrode is placed on the surface of the brain and connected to a programmable battery in the chest. The strength of stimulation can be individually adjusted by changing the voltage of stimulation. A too high voltage will produce side effects (e.g. seizures) while a too low voltage will not provide pain control. The aim of this study is to analyze the optimal stimulation timing parameters in patients already implanted with MCS and have received good pain relief. The investigators wish to cyclize on/off MCS in order to save the battery life of the stimulator and also decrease stimulus habituation. The investigators hope to determine these timing parameters while maintaining optimal pain relief.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuropathic Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Original Setting- MCS 30 min off/0 min off
Arm Type
Active Comparator
Arm Description
Patients at baseline with their original MCS settings: on 30 minutes, off 0 minutes in any single half-hour.
Arm Title
MCS 25 min on/5 min off
Arm Type
Experimental
Arm Description
Patient MCS settings programmed to: on 25 minutes, off 5 minutes in any single half-hour.
Arm Title
MCS 20 min on/10 min off
Arm Type
Experimental
Arm Description
Patient MCS settings programmed to: on 20 minutes, off 10 minutes in any single half-hour.
Arm Title
MCS 15 min on/15 min off
Arm Type
Experimental
Arm Description
Patient MCS settings programmed to: on 15 minutes, off 15 minutes in any single hour.
Intervention Type
Device
Intervention Name(s)
motor cortex stimulation (Change of Stimulation Timing)
Primary Outcome Measure Information:
Title
Change in Pain measured on the Visual Analogue Scale (VAS) with different stimulation settings
Time Frame
At the End of each trial period, typically 14 days after change in stimulation settings
Secondary Outcome Measure Information:
Title
Quality of Life assessment with the SF-36 questionnaire
Time Frame
At the end of each trial period, typically at 14 days after change in stimulation settings
Other Pre-specified Outcome Measures:
Title
Pain assessment with the McGill pain questionnaire to record impact of pain
Time Frame
At the end of each trial period, typically 14 days after change in stimulation setting

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patient more than 18 years of age Chronic neuropathic pain effectively treated with motor cortex stimulation Stable medication during the trial Willing and able to comply with the study protocol and to return per the follow-up visit schedule and able to provide informed consent. Exclusion Criteria: Evidence of an active disruptive psychiatric disorder or other known condition significant enough to impact the perception of pain, compliance to intervention and/or ability to evaluate treatment outcome as determined by the investigator Technical malfunction of the MCS device History of seizures Unable to provide informed consent
Facility Information:
Facility Name
The Vancouver General Hospital
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z 4E3
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
1705329
Citation
Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Treatment of thalamic pain by chronic motor cortex stimulation. Pacing Clin Electrophysiol. 1991 Jan;14(1):131-4. doi: 10.1111/j.1540-8159.1991.tb04058.x.
Results Reference
result
PubMed Identifier
1792954
Citation
Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir Suppl (Wien). 1991;52:137-9. doi: 10.1007/978-3-7091-9160-6_37.
Results Reference
result
PubMed Identifier
8657427
Citation
Peyron R, Garcia-Larrea L, Deiber MP, Cinotti L, Convers P, Sindou M, Mauguiere F, Laurent B. Electrical stimulation of precentral cortical area in the treatment of central pain: electrophysiological and PET study. Pain. 1995 Sep;62(3):275-286. doi: 10.1016/0304-3959(94)00211-V.
Results Reference
result
PubMed Identifier
18541887
Citation
Lima MC, Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008 Jun 10;70(24):2329-37. doi: 10.1212/01.wnl.0000314649.38527.93.
Results Reference
result

Learn more about this trial

Cyclization of Motor Cortex Stimulation

We'll reach out to this number within 24 hrs